Attached files

file filename
10-K - FORM 10-K - BIOJECT MEDICAL TECHNOLOGIES INCd10k.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - BIOJECT MEDICAL TECHNOLOGIES INCdex311.htm
EX-32.2 - SECTION 906 CFO CERTIFICATION - BIOJECT MEDICAL TECHNOLOGIES INCdex322.htm
EX-32.1 - SECTION 906 CEO CERTIFICATION - BIOJECT MEDICAL TECHNOLOGIES INCdex321.htm
EX-31.2 - SECTION 302 CFO CERTIFICATION - BIOJECT MEDICAL TECHNOLOGIES INCdex312.htm

Exhibit 23

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to incorporation by reference in the registration statements (Nos. 033-94400, 033-56454, 033-42156, 333-37017, 333-38206, 333-38212, 333-48632, 333-48634, 333-73868, 333-108514 333-128618, 333-153195, 333-158757, and 333-163293) on Form S-8 our report dated March 30, 2010, relating to the consolidated financial statements appearing in this Annual Report on Form 10-K of Bioject Medical Technologies Inc. for the year ended December 31, 2009.

Our audit report dated March 30, 2010, contains an explanatory paragraph that states that the Company’s recurring losses, negative cash flows from operations, and accumulated deficit raise substantial doubt about the entity’s ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of that uncertainty.

/s/ Moss Adams LLP

Portland, Oregon

March 30, 2010